SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-14-001756
Filing Date
2014-03-04
Accepted
2014-03-04 14:01:06
Documents
12
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2218507z10-k.htm 10-K 1174374
2 EX-23.1 a2218507zex-23_1.htm EX-23.1 5600
3 EX-31.1 a2218507zex-31_1.htm EX-31.1 8195
4 EX-31.2 a2218507zex-31_2.htm EX-31.2 8227
5 EX-32.1 a2218507zex-32_1.htm EX-32.1 5283
12 G194047.JPG g194047.jpg GRAPHIC 40207
  Complete submission text file 0001047469-14-001756.txt   8535523

Data Files

Seq Description Document Type Size
6 EX-101.INS rigl-20131231.xml EX-101.INS 1280486
7 EX-101.SCH rigl-20131231.xsd EX-101.SCH 65242
8 EX-101.CAL rigl-20131231_cal.xml EX-101.CAL 62694
9 EX-101.LAB rigl-20131231_lab.xml EX-101.LAB 999440
10 EX-101.PRE rigl-20131231_pre.xml EX-101.PRE 493363
11 EX-101.DEF rigl-20131231_def.xml EX-101.DEF 299258
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29889 | Film No.: 14663823
SIC: 2834 Pharmaceutical Preparations